Who are the luminaries driving the biggest advances in biopharma R&D? Endpoints News is asking for your nominations for a special report
In biopharma, driving a drug to market is the ultimate goal — but none of that happens without a strong research and development program. At the most successful companies, those R&D efforts are spearheaded by true innovators in the field who are always looking for that next novel mechanism of action or breakthrough safety profile.
Now, Endpoints News is asking you to tell us who those guiding lights are.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.